Millennium Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-159,100
Closed -$8.19M 3818
2015
Q4
$8.19M Buy
159,100
+9,100
+6% +$441K 0.02% 1037
2015
Q3
$6.39M Buy
+150,000
New +$7.24M 0.01% 1196

Millennium Management's PTLA Position: Q3 2020 in Review

Millennium Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 683,381 shares — an estimated $12.3M sold.

Millennium Management first reported a position in PTLA in Q2 2013 and held it in 27 quarters. The position peaked at $84.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Millennium Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Millennium Management sold 683,381 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.3M.
  • Millennium Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
  • Millennium Management's Portola Pharmaceuticals, Inc. position peaked at $84.8M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.